How We Work

LIFE bioCEEd is a leading investor, actively supporting early-stage research and serving as a catalyst for translating visionary concepts into tangible healthcare solutions.

1

Sourcing Innovation

Our venture development journey commences with actively sourcing promising and innovative applied research projects from univerisities, hospitals and research institutions. We scout for visionary ideas that align with our commitment to advancing healthcare.
2

Initial Assessment

Once receiving the initial information & data, we begin with conducting an initial assessment, where we meticulously verify the hypotheses underlying the identified projects. Our team of fund managers and scientific board members assesses scientific validity, market potential, IP protection, and feasibility, ensuring the foundation for success is sufficient.
3

Matrix Assessment 
/ Due Diligence

If the project passess the initial assessment round, rigorous due diligence follows, where we dive deeper into the project details and build a roadmap of next steps by evaluating the science merit, competitive landscape, in-vivo/in-vitro data, IP, market access routes, medical problem, etc. Matrix serves as a core internal document for the investment decision by LIFE bioCEEd investment committee.
4

Investment process

support of applied research projects within two investment rounds

1st round

up to € 400,000

Bridging the gap between applied research and market readiness of the project and obtaining primary data


  • Validation of research outcomes
  • Intellectual property Protection & Development
  • Early-stage product development (“PoC”)
  • Regulatory pathway assessment
  • Operational and team costs
Condition for 2nd round

Meeting defined milestones

2nd round

€ 1,500,000 – € 3,000,000

Establishment of a spin-off venture with the aim of ensuring all the requirements for the product to be successfully launched on the market


  • Venture building (spin-off formation)
  • Pre-clinical/clinical testing
  • Preparation for regulatory approvals
  • Technology/production scaling
  • Market entry & commercialization
  • Strengthening the team and operational capacities

For more information on investment option with LIFE bioCEEd, contact us at inquiries@bioceed.eu

LIFE BioCEEd a.s., a venture capital entity

IČ: 21686386

Biotech Incubator 4MEDI

Dr. Slabihoudka 6232/11

708 00 Ostrava

Czech Republic


LIFE BioCEEd nespadá dle § 15 ZISIF pod dohled ČNB.

Website developed by David Veselý